Huaren Pharmaceutical Co., Ltd.
Huaren Pharmaceutical Co., Ltd., headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality medicinal products. Founded in 2001, the company has established a strong presence in both domestic and international markets, focusing on innovative solutions in areas such as oncology, cardiology, and infectious diseases. With a commitment to excellence, Huaren Pharmaceutical offers a diverse portfolio of core products, including generic medications and proprietary formulations that stand out for their efficacy and safety. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. Recognised for its dedication to quality and innovation, Huaren Pharmaceutical continues to contribute to global health advancements while maintaining a strong reputation in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Huaren Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huaren Pharmaceutical Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huaren Pharmaceutical Co., Ltd.'s reported carbon emissions
Huaren Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Huaren Pharmaceutical's climate commitments remain unclear, and there is no information available regarding their strategies for reducing carbon emissions or their alignment with industry standards such as the Science Based Targets initiative (SBTi). The company does not inherit emissions data from a parent organisation, indicating that their climate impact and commitments are independently assessed. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and set measurable targets to mitigate their environmental impact. However, without specific data or commitments, Huaren Pharmaceutical's position on climate action remains undefined.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huaren Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
